A207 RIPK2 AND AMPK AS EMERGING THERAPEUTIC TARGETS FOR INFLAMMATORY BOWEL DISEASE

BACKGROUND: Persistent inflammation can trigger altered epigenetic, inflammation and bioenergetics states. Inflammatory bowel disease (IBD) is a heterogeneous disease with an abnormal inflammatory state and subsequent metabolic syndrome disorder. Current IBD therapeutics are directed to inhibit infl...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Can Assoc Gastroenterol
Hoofdauteurs: Guo, Y, Dieleman, L A, Dooky, H, Joshi, H, Wine, E, Baksh, S
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2020
Onderwerpen:
Poster Presentation
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7043684/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwz047.206
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items